Stockreport

Keros Therapeutics, Inc. (NASDAQ:KROS) institutional owners may be pleased with recent gains after 2.4% loss over the past year [Yahoo! Finance]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF A total of 8 investors have a majority stake in the company with 50% ownership Analyst forecasts along with ownership data serve to give a strong idea about prospects [Read more]